Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Browse over 450 CME/CE courses on FranceFoundation.com
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA